[헬스코리아뉴스] The Korea Food and Drug Administration(KFDA) has approved the first generic of Tamlflu(Roche) which Chong Kun Dang has been developing as new drug for treatment of new flu.
KFDA announced on December 8 that the agency has approved the first generic of Tamlflu 30mg, 45mg and 75mg, based on the Bioequivalence Test of Chong Kun Dang.
In addition, more than 10 domestic drug makers such as Hanmi Pharmaceutical, Daewoong Pharm and SK chemical has submitted dates on the Bioequivalence Test to the KFDA.
Some specialists are expecting more approvements of Tamlflu's generic would be follow.
◆ 식약청 "종근당 신종플루 치료제 타미플루 제네릭 첫 승인"
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지
